Development of a regenerative medical product for advanced chronic limb ischemia

A plan to advance development of a regenerative medical product for advanced chronic limb ischemia, using funds raised through the 20th Stock Acquisition Rights.

Companies1How many companies write about this.

Threads1One company can carry more than one thread here.

PeriodFY2025 →Last written FY2025

Directionhelps1 helps · 0 hurts · 0 flat

Loading